Literature DB >> 19712876

Keto-acid therapy in predialysis chronic kidney disease patients: consensus statements.

Michel Aparicio, Noël J M Cano, Adamasco Cupisti, Tevfik Ecder, Denis Fouque, Liliana Garneata, Hung-Hsiang Liou, Shanyan Lin, Hans-Jürgen Schober-Halstenberg, Vladimír Teplan, Gábor Zakar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712876     DOI: 10.1053/j.jrn.2009.06.013

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


× No keyword cloud information.
  5 in total

Review 1.  Diets and enteral supplements for improving outcomes in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Noël J Cano; Klemens Budde; Charles Chazot; Csaba P Kovesdy; Robert H Mak; Rajnish Mehrotra; Dominic S Raj; Ashwini R Sehgal; Peter Stenvinkel; T Alp Ikizler
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

2.  Metabolic engineering of Corynebacterium glutamicum for 2-ketoisovalerate production.

Authors:  Felix S Krause; Bastian Blombach; Bernhard J Eikmanns
Journal:  Appl Environ Microbiol       Date:  2010-10-08       Impact factor: 4.792

Review 3.  Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines?

Authors:  Giorgina Barbara Piccoli; Irene Capizzi; Federica Neve Vigotti; Filomena Leone; Claudia D'Alessandro; Domenica Giuffrida; Marta Nazha; Simona Roggero; Nicoletta Colombi; Giuseppe Mauro; Natascia Castelluccia; Adamasco Cupisti; Paolo Avagnina
Journal:  BMC Nephrol       Date:  2016-07-08       Impact factor: 2.388

4.  Evaluation of Metabolic Engineering Strategies on 2-Ketoisovalerate Production by Escherichia coli.

Authors:  Li Zhou; Ying Zhu; Zhongzhe Yuan; Guangqing Liu; Zijin Sun; Shiyu Du; He Liu; Yating Li; Haili Liu; Zhemin Zhou
Journal:  Appl Environ Microbiol       Date:  2022-08-18       Impact factor: 5.005

Review 5.  Bio-based production of organic acids with Corynebacterium glutamicum.

Authors:  Stefan Wieschalka; Bastian Blombach; Michael Bott; Bernhard J Eikmanns
Journal:  Microb Biotechnol       Date:  2012-12-02       Impact factor: 5.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.